Cash Flow Statement
Growth Metrics

Biolife Solutions (BLFS) Receivables - Net (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Receivables - Net for 16 consecutive years, with $8.0 million as the latest value for Q4 2025.

  • Quarterly Receivables - Net fell 6.17% to $8.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.0 million through Dec 2025, down 6.17% year-over-year, with the annual reading at $8.0 million for FY2025, 6.17% down from the prior year.
  • Receivables - Net for Q4 2025 was $8.0 million at Biolife Solutions, down from $10.8 million in the prior quarter.
  • The five-year high for Receivables - Net was $33.9 million in Q4 2022, with the low at $7.9 million in Q4 2023.
  • Average Receivables - Net over 5 years is $19.4 million, with a median of $19.4 million recorded in 2021.
  • The sharpest move saw Receivables - Net skyrocketed 384.79% in 2021, then tumbled 76.73% in 2023.
  • Over 5 years, Receivables - Net stood at $23.2 million in 2021, then skyrocketed by 46.17% to $33.9 million in 2022, then crashed by 76.73% to $7.9 million in 2023, then rose by 7.32% to $8.5 million in 2024, then decreased by 6.17% to $8.0 million in 2025.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $8.0 million, $10.8 million, and $10.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.